Last reviewed · How we verify
NCT01517139
Diet and Nutrition Pilot Study for Chinese Adolescents and Their Mothers
trial in Methylation in 278 participants. Completed in 27 August 2013.
31 July 2012
Quick facts
| Lead sponsor | National Cancer Institute (NCI) |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 278 |
| Start date | 1 March 2012 |
| Primary completion | 31 July 2012 |
| Estimated completion | 27 August 2013 |
| Sites | 1 location across China |
Conditions studied
- Methylation — all drugs for Methylation →
- Body Composition — all drugs for Body Composition →
- Physical Activity — all drugs for Physical Activity →
- Puberty — all drugs for Puberty →
Sponsor
National Cancer Institute (NCI)
Who can join
Adults 15 to 45, any sex, with Methylation or Body Composition. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: \- Researchers want to collect information on diet, physical activity, and sun exposure in children and young adults. The data can provide information on the effect these factors might have on the development of cancer and other diseases. Information collected only from adults does not accurately measure these factors. To collect more accurate information, both mothers and children will provide information. Study participants will be from Hebei province in northeastern China and Jiangsu province in eastern China. Objectives: \- To collect and study diet, activity, and sun exposure data from Chinese adolescents and their mothers. Eligibility: * Adolescents between 15 and 17 years of age from Hebei and Jiangsu provinces in China. * Mothers of the study adolescents. Design: * Participants will answer questions about their diet, physical activity, and time in the sun. * Participants will wear a pedometer to measure activity for 7 days. They will also wear a badge to measure sun exposure for 3 days. * Participants will record their activities and food and drinks consumed for 3 days. Urine samples will be collected for a full day. * Participants will have a grip strength test. On the last day of the study, they will provide blood, saliva, and toenail samples. * A smaller separate group of adolescents will provide saliva samples only and complete a food questionnaire.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT01517139
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other National Cancer Institute (NCI) trials
Trials by the same sponsor.
- NCT07147231 — Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cem · Phase 1, PHASE2 · recruiting
- NCT07572123 — Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem · Phase 2, PHASE3 · not yet recruiting
- NCT07281417 — Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasa · Phase 2 · recruiting
- NCT07012044 — A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After · Phase 1 · not yet recruiting
- NCT07437950 — Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A Myel · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01517139 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Cancer Institute (NCI)
- Last refreshed: 3 March 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01517139.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing